OneSource Specialty Pharma Limited has intimated the stock exchanges about a scheduled meeting of its Board of Directors. The meeting is set to be held on Friday, July 24, 2026. The primary agenda for this meeting is to consider and approve the company's unaudited financial results for the quarter ended June 30, 2026. Both standalone and consolidated financial results will be reviewed and approved.
Additionally, the company has implemented a trading blackout period in compliance with its Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for all Designated Persons of the company was closed starting July 1, 2026, for the quarter ended June 30, 2026. The trading window will remain closed until 48 hours after the financial results have been officially disseminated to the public.
This intimation is made specifically under Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Financial Impact
Financial results for the quarter are pending board approval. No specific financial figures or impacts are disclosed in this intimation.